Scoop has an Ethical Paywall
Living Cell Technologies - Latest News [Page 4]
LCT Gains Additional Benefit from Diabecell
Monday, 6 April 2009, 4:38 pm | Living Cell Technologies
April 6, 2009 – Sydney, Australia, Auckland, New Zealand– Living Cell Technologies Limited (ASX: LCT; OTCQX: LVCLY) reports insulin independence in a patient with insulin dependent type 1 diabetes who received DIABECELL®, its encapsulated insulin-producing ... More >>
Sustained Benefit with DIABECELL® Implants
Wednesday, 11 February 2009, 1:28 pm | Living Cell Technologies
February 11, 2009 – Sydney, Australia, Auckland, New Zealand– Living Cell Technologies Limited (ASX: LCT; OTCQX: LVCLY) reports positive interim results from the long term follow-up of insulin dependent diabetes patients in the Phase I/IIa clinical trial ... More >>
Preclinical Studies Suggest Effect On Parkinson's
Thursday, 11 December 2008, 12:52 pm | Living Cell Technologies
Living Cell Technologies Limited (ASX: LCT; OTCQX: LVCLY) today reported that its pipeline product, NeurotrophinCell (NtCell), encapsulated brain choroid plexus cells, may be beneficial in Parkinson’s disease. More >>
Living Cell Technologies Expands Management Team
Tuesday, 29 July 2008, 1:37 pm | Living Cell Technologies
Living Cell Technologies Limited (ASX: LCT; OTCQX: LVCLY) today announced the expansion of its management team and the appointment of one of its directors, Dr. Robert Caspari, M.D., as Chief Executive Officer of the Company. More >>
Clinical Benefit for All Patients in Diabetes Tria
Tuesday, 22 July 2008, 1:44 pm | Living Cell Technologies
July 22, 2008, Melbourne, Australia and Auckland, New Zealand. Living Cell Technologies Limited (ASX:LCT; OTCQX: LVCLY) today released further interim results describing clinical benefit in all patients who have received implants of DiabeCell®, the Company’s ... More >>
Living Cell Technologies Hosts Diabetes Seminar
Thursday, 17 July 2008, 4:44 pm | Living Cell Technologies
July 17, 2008, Melbourne, Australia and Auckland, New Zealand. Living Cell Technologies Limited (ASX:LCT; OTC: LVCLY.PK) today announced that Professor Bob Elliott, Medical Director of LCT, will host a seminar on Friday August 8, 2008 in Auckland, New Zealand ... More >>
Diabetes Clinical Trial in New Zealand
Monday, 30 June 2008, 1:28 pm | Living Cell Technologies
June 26, 2008 – Melbourne, Australia and Auckland, New Zealand - Living Cell Technologies Limited (ASX:LCT; OTCQX: LVCLY) today announced that it has received a letter from the New Zealand Minister of Health, the Honorable David Cunliffe, indicating that ... More >>
Insulin Delivery from Implants
Wednesday, 25 June 2008, 4:33 pm | Living Cell Technologies
June 25, 2008 – Melbourne, Australia and Auckland, New Zealand - Living Cell Technologies Limited (ASX:LCT; OTC: LVCLY) today reported that patients in the DiabeCell® phase I/IIa diabetes clinical trial had porcine insulin in their blood samples providing ... More >>
LCT Expands Diabetes Clinical Trial
Thursday, 5 June 2008, 1:05 pm | Living Cell Technologies
June 5, 2008 – Melbourne, Australia and Auckland, New Zealand - Living Cell Technologies Limited (ASX:LCT; OTC: LVCLY) today announced that the positive preliminary data from its first clinical trial of DiabeCell® for insulin dependent Type 1 diabetes ... More >>
Living Cell Technologies Lists on OTCQX
Tuesday, 3 June 2008, 12:02 am | Living Cell Technologies
Living Cell Technologies Limited (ASX:LCT; OTCQX:LVCLY) today announced that it has listed its American Depositary Receipts (“ADRs”) on the International OTCQX and began trading Monday, June 2nd in the United States. LCT's ordinary shares are listed ... More >>
Living Cell Technologies Presents New Technology
Monday, 12 May 2008, 5:22 pm | Living Cell Technologies
May 12, 2008 - Melbourne, Australia and Auckland, New Zealand - Living Cell Technologies Limited (ASX:LCT; OTC: LVCLY.PK) today announced that the Company has been invited to deliver a presentation on its unique encapsulation technology at the International ... More >>
LCT Prepares to List on International OTCQX
Thursday, 8 May 2008, 3:37 pm | Living Cell Technologies
Living Cell Technologies Limited (ASX:LCT; OTC: LVCLY.PK) today announced it has applied to list its American Depository Receipt (ADR) program on the International OTCQX to increase the Company’s exposure to U.S. investors. More >>
LCT's Proprietary Nanobiocapsules at NZBio 2008
Wednesday, 2 April 2008, 11:57 am | Living Cell Technologies
Living Cell Technologies Limited (ASX:LCT; OTC: LVCLY.PK) today announced that Dr Paul Tan, LCT CEO and Dr Anil K Anal, LCT Material Scientist, presented data at a session on nanotechnology at the NZBio 2008 Conference in Auckland, New Zealand. ... More >>
Compelling Interim Diabetes Trial Results
Monday, 31 March 2008, 12:33 am | Living Cell Technologies
Living Cell Technologies Limited (ASX:LCT; OTC: LVCLY.PK) today announced new positive 6 month interim results from the Phase I/IIa clinical trial of DiabeCell® for the treatment of type 1 diabetes at the International Diabetes Federation (IDF) Congress ... More >>
Living Cell Technologies issued fourth US patent
Monday, 17 March 2008, 4:03 pm | Living Cell Technologies
Living Cell Technologies Limited (ASX:LCT; OTC: LVCLY.PK) today announced that a United States patent has been issued for the company’s lead product DiabeCell®, currently in development for Type I diabetes. More >>
Living Cell Technologies Appoints New US Based Dr
Wednesday, 9 January 2008, 3:53 pm | Living Cell Technologies
Living Cell Technologies Limited (ASX:LCT; OTC: LVCLY.PK) today announced the appointment of Dr. Robert Caspari of Boulder, Colorado to LCT’s Board of Directors as a Non Executive Director. More >>
LCT to Receive US$6.0M through Exercise of Option
Wednesday, 9 January 2008, 1:47 pm | Living Cell Technologies
Living Cell Technologies Limited (ASX:LCT; OTC: LVCLY.PK) today announced that Palmert Members Limited (a British Virgin Island company) will purchase 24,150,408 ordinary shares of LCT at A$0.29 per share for an aggregate purchase price of US$6.0 million. ... More >>
Living Cell Tech Receives A$6.0M Capital Placement
Friday, 30 November 2007, 5:43 pm | Living Cell Technologies
November 30, 2007 – Melbourne, Australia and Auckland, New Zealand - Living Cell Technologies Limited (ASX:LCT; OTC: LVCLY.PK) today announced that it has received A$6.0 million in funds for the capital placement announced on October 30. Shareholders ... More >>
Clinical Trial Progress at Annual General Meeting
Tuesday, 27 November 2007, 4:37 pm | Living Cell Technologies
November 27, 2007 – Melbourne, Australia and Auckland, New Zealand Living Cell Technologies Limited (ASX:LCT; OTC: LVCLY.PK) today updated shareholders at its Annual General Meeting on the Company’s Russian clinical trial, the status of its New ... More >>
Living Cell Technologies to Cancel Rights at $O.20
Friday, 23 November 2007, 11:04 am | Living Cell Technologies
Living Cell Technologies to Cancel Rights at A$O.20 Following A$6M Placement at $0.30 Per Share More >>
